Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Developed at Monash University in Australia, AOD9604 was designed to isolate the lipolytic activity attributed to the C-terminal region of hGH while excluding the growth-promoting and diabetogenic effects associated with the full-length hormone
There's no prescription drug containing BPC-157 that's legally approved for human use in treating injuries, inflammation, gut issues, or pain
These effects limit growth hormones suitability for many individuals, particularly those with metabolic syndrome, diabetes, or cancer concerns
Prevents bacterial growth for up to 28 days after first use
They claim the product is for research or not for human consumption to dodge FDA jurisdiction, Holt says
Our staff members are being required to wear gloves and masks at all times, continuously disinfecting surfaces and maintaining as much distance as possible
US$ 23.85
US$ 25.41
